Impax Asset Management Group plc Raises Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Impax Asset Management Group plc boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 31.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,359,798 shares of the medical device company’s stock after acquiring an additional 558,886 shares during the period. Impax Asset Management Group plc owned 1.19% of Cooper Companies worth $205,511,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. raised its position in shares of Cooper Companies by 303.0% in the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after purchasing an additional 17,367,502 shares during the last quarter. Capital World Investors raised its holdings in shares of Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after buying an additional 4,246,519 shares during the last quarter. Janus Henderson Group PLC lifted its stake in shares of Cooper Companies by 279.8% during the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after buying an additional 2,532,186 shares during the period. Bessemer Group Inc. grew its holdings in shares of Cooper Companies by 305.2% during the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after buying an additional 1,507,049 shares during the last quarter. Finally, Swedbank AB acquired a new position in shares of Cooper Companies in the 1st quarter valued at $139,246,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Price Performance

Shares of NASDAQ:COO traded up $0.74 during midday trading on Friday, reaching $107.24. 41,895 shares of the company’s stock traded hands, compared to its average volume of 1,121,100. The company has a fifty day simple moving average of $92.92 and a two-hundred day simple moving average of $94.55. The Cooper Companies, Inc. has a 1 year low of $75.93 and a 1 year high of $107.82. The company has a market cap of $21.35 billion, a P/E ratio of 62.65, a PEG ratio of 2.56 and a beta of 0.98. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.14 and a current ratio of 1.99.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. The business had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company’s revenue was up 7.8% compared to the same quarter last year. During the same period last year, the firm posted $0.84 earnings per share. Equities analysts predict that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird upped their target price on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and boosted their target price for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Finally, Piper Sandler lifted their price objective on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus price target of $113.61.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.